Merit Medical Systems (MMSI) Projected to Post Quarterly Earnings on Thursday

Key Points

• Merit Medical Systems is expected to report Q3 2026 results after Thursday’s close, with analysts forecasting $1.04 in EPS and $410.34 million in revenue. The company’s fiscal-year 2026 EPS guidance is $4.25–$4.35.
• The company’s previous quarter exceeded expectations, posting $1.19 EPS versus the $0.96 consensus and $418.84 million in revenue, up 9.5% year over year.
• Analysts maintain a “Moderate Buy” consensus with a $100 average price target; shares recently traded at $91.40, near their 12-month high of $94.75.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) is expected to issue its Q3 2026 results after the market closes on Thursday, October 29th. Analysts expect Merit Medical Systems to post earnings of $1.04 per share and revenue of $410.34 million for the quarter. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Interested persons are encouraged to explore the company's upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, October 29, 2026 at 4:30 PM ET.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%. The company had revenue of $418.84 million during the quarter, compared to analysts' expectations of $405.25 million. During the same quarter in the prior year, the firm posted $1.01 EPS. Merit Medical Systems's quarterly revenue was up 9.5% compared to the same quarter last year. On average, analysts expect Merit Medical Systems to post $3.84 EPS for the current fiscal year and $4.17 EPS for the next fiscal year.

Merit Medical Systems Stock Up 0.2%

Shares of MMSI opened at $91.40 on Thursday. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44. Merit Medical Systems has a 12 month low of $59.74 and a 12 month high of $94.75. The stock's 50 day moving average is $88.31 and its two-hundred day moving average is $76.50. The firm has a market cap of $5.46 billion, a P/E ratio of 37.77, a PEG ratio of 2.28 and a beta of 0.51.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on MMSI. Piper Sandler increased their target price on Merit Medical Systems from $96.00 to $106.00 and gave the company an "overweight" rating in a research report on Friday, July 31st. JPMorgan Chase & Co. upped their price objective on shares of Merit Medical Systems from $77.00 to $95.00 and gave the stock an "overweight" rating in a research report on Friday, July 31st. Wells Fargo & Company increased their price objective on shares of Merit Medical Systems from $74.00 to $83.00 and gave the company an "equal weight" rating in a report on Friday, July 31st. Canaccord Genuity Group increased their price objective on shares of Merit Medical Systems from $85.00 to $94.00 and gave the company a "buy" rating in a report on Friday, July 31st. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $101.00 target price on shares of Merit Medical Systems in a research report on Tuesday, September 29th. Eight research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat.com, Merit Medical Systems currently has a consensus rating of "Moderate Buy" and a consensus target price of $100.00.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company's product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.